Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide once weekly for moderate Parkinson's disease
2013-003363-64Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Exenatide once weekly with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Mar 2014; status: completed.
02
Drugs
exenatide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2013-003363-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003363-64.